ERBB2 and breast cancer: Tsang et al. [102] reported that NGFR/p75NTR could represent a potential marker for specific molecular subtypes of breast cancer through the comparison of its immunohistochemical expression in 602 specimens of luminal A, luminal B, HER2-overexpressed, basal-like and unclassified subtypes.